SCHEMBL5376782

SCHEMBL5376782

CCc1ccc(S(=O)(=O)N(c2ccc(C(F)(F)F)cc2)c2ccc3ocnc3c2)cc1C(=O)OC

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GAA P10253 1/20 0.36
ALDH1A1 P00352 1/20 0.36
TSHR P16473 1/20 0.36
CSF1R P07333 2/20 0.34
HIF1A Q16665 1/20 0.34
RXRA P19793 1/20 0.34
RXRB P28702 1/20 0.34
RXRG P48443 1/20 0.34
RORC P51449 1/20 0.34
SMN1; SMN2 Q16637 3/20 0.33
HDAC8 Q9BY41 2/20 0.33
TP53 P04637 2/20 0.33
MAPT P10636 2/20 0.33
HDAC3 O15379 1/20 0.33
HDAC11 Q96DB2 1/20 0.33
HDAC6 Q9UBN7 1/20 0.33
KMT2A Q03164 1/20 0.33
CFTR P13569 1/20 0.33
LMNA P02545 1/20 0.33
PKM P14618 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5373225 0.92 TP53 (0.36) GAAALDH1A1TSHRHIF1ASMN1; SMN2
SCHEMBL5376744 0.91 ALDH1A1 (0.38) ALDH1A1TSHRSMN1; SMN2HDAC8TP53
SCHEMBL5368411 0.91 RXRA (0.39) GAAALDH1A1RXRARXRBRXRG
SCHEMBL5367888 0.90 GAA (0.37) GAAALDH1A1TSHRCSF1RHIF1A
SCHEMBL5368704 0.83 TRPM8 (0.41) ALDH1A1PKM
SCHEMBL5391241 0.82 ALDH1A1 (0.35) GAAALDH1A1RXRARXRBRXRG
SCHEMBL5921908 0.82 TP53 (0.39) ALDH1A1TSHRHIF1ASMN1; SMN2TP53
SCHEMBL5373830 0.81 RXRA (0.40) GAAALDH1A1CSF1RRXRARXRB
SCHEMBL5382107 0.80 SMN1; SMN2 (0.35) ALDH1A1SMN1; SMN2TP53MAPTKMT2A
SCHEMBL5921895 0.80 TP53 (0.38) ALDH1A1TSHRSMN1; SMN2TP53MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7262318-B2 Substituted heteroaryl- and phenylsulfamoyl compounds PFIZER, INC. (US) 2007-08-28 US disclosed
US-20050228015-A1 Substituted heteroaryl- and phenylsulfamoyl compounds PFIZER INC 2005-10-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050228015-A1 Substituted heteroaryl- and phenylsulfamoyl compounds PPARA, PPARG, PPARD GAA 1367/4885ALDH1A1 2956/4885TSHR 400/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.